Skip to main content
. 2022 Dec 1;10(4):118. doi: 10.3390/diseases10040118

Figure 1.

Figure 1

A schematic representation shows how TGM/CGM can simultaneously bind to the non-overlapping regions of the RBD of SARS-CoV-2 spike protein to prevent the virus attachment to human host cells. Abbreviations: RBD, receptor-binding domain; TGM/CGM, tixagevimab and cilgavimab; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.